Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Honkoop, R. Loijmans, E. Termeer, J. Snoeck-Stroband, P. Assendelft, P. Sterk, G. ter Riet, T. Schermer, J. Sont, The ACCURATE Study Group (Leiden, Amsterdam, Nijmegen, Netherlands). A cluster randomized trial comparing strict, partial, and FeNO-guided asthma control strategies in primary care. Eur Respir J 2013; 42: Suppl. 57, 2007

Member's Comments

No comment yet.

Related content which might interest you: Excess inhaled corticosteroid adherence may be a marker of uncontrolled asthma Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 Physical training does not increase allergic inflammation in asthmatic children Source: Eur Respir J 2008; 32: 1570-1575 Year: 2008 Supplemental dietary nitrate for COPD: A randomized, double-blind, placebo-controlled, crossover trial Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation Year: 2013 REG study: Real-life, longitudinal ICS adherence patterns in a UK asthma population Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015 Cost savings using fractional exhaled nitric oxide (FeNO) testing in asthma management by specialists Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 The role of adherence to inhaled corticosteroids (ICS) in the relationship between blood eosinophilia and asthma control Source: International Congress 2016 – Asthma management in primary care Year: 2016 In whom should regular asthma controller therapy be initiated? Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Asthma rehabilitation at high vs. low altitude and its impact on exhaled nitric oxide and sensitization patterns: randomized parallel-group trial Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Combination therapy versus separate therapy in real-life primary care asthma patients Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015 Late Breaking Abstract - Can a self-management plan, which includes a four-fold increase in inhaled corticosteroid dose, reduce severe asthma exacerbations: a randomised, pragmatic trial. Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Effectiveness of a pharmacist intervention for asthma control improvement: randomised controlled trial Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care Year: 2007 Efficacy and safety of abediterol (LAS100977) in stable asthma: Phase II, randomized, crossover study Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Small airway dysfunction and its role in pediatric asthma control assessment Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016 A study of exhaled NO (FENO) measurement used to determine asthma control, dose of inhaled corticosteroid and cost in a developing country Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 The impact of fractional exhaled nitric oxide (FeNO) measurement on treatment decision making in the specialist care of established asthma Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Effects of low- vs high-dose fluticasone/formoterol combination therapy on AMP challenge in asthmatic patients Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Further evidence that FeNO directed therapy reduces asthma exacerbations Source: International Congress 2014 – Airway biomarkers Year: 2014 Efficacy and safety of isoproterenol continuous inhalation treatment for acute severe exacerbation of asthma in children; a randomized, double-blind controlled study Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015 Randomized, controlled study of the impact of a mobile health tool on asthma SABA use, control and adherence Source: International Congress 2016 – Non-inflammatory assessment of airway disorders Year: 2016